Related Experiment Video

Updated: May 24, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death

Shani Bialik1, Adi Kimchi

  • 1Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel. shanib@weizmann.ac.il

Seminars in Cancer Biology
|June 29, 2004
PubMed

Insights

Dysregulated cell death is linked to disease. DAP-kinase (DAPk), a calcium-regulated kinase, promotes cell death and is a potential therapeutic target for various diseases.

Area of Science:

  • Molecular biology
  • Cellular biology
  • Biochemistry

Background:

  • Misregulated cell death, including excessive or insufficient cell removal, is implicated in numerous diseases.
  • DAP-kinase (DAPk) is a key molecular regulator of programmed cell death.
  • DAPk's role in disease pathogenesis necessitates understanding its regulatory mechanisms.

Purpose of the Study:

  • To present a structure-functional analysis of DAP-kinase (DAPk).
  • To explore DAPk as a potential therapeutic target for diseases involving cell death.
  • To examine DAPk's modulation in disease models affecting cell death.

Main Methods:

  • Structure-functional analysis of DAP-kinase.
  • Investigation of calcium-regulated kinase activity.
  • Examination of disease models relevant to cell death.

Main Results:

  • DAP-kinase is a calcium-regulated Ser/Thr kinase that promotes cell death.
  • Structural and functional insights into DAPk's mechanism of action were elucidated.
  • The study highlights DAPk's potential role in various disease contexts.

Conclusions:

  • DAP-kinase is a critical regulator of cell death with therapeutic potential.
  • Modulating DAPk activity may offer novel treatment strategies for diseases associated with cell death.
  • Further research into DAPk in specific disease models is warranted.

More Related Videos

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: